Application no. and date | 13809694.6 (espacenet) (Federated) (European Patent Register), 20130625 | Patent/reg. no. and date | DK/EP 2864479, 20180815 | Publication date | 20150429 | Priority no. and date | US 201261664083 P, 20120625, US 201261738959 P, 20121218, US 201361750939 P, 20130110, US 201361755617 P, 20130123, US 201361772925 P, 20130305 | EP pub. no. and date |
EP 2864479 20150429 | Effective date | | Applicant/owner | Baylor College Of Medicine, Mail Stop BM210 One Baylor Plaza
Houston, Texas 77030-3411, US, Ionis Pharmaceuticals, Inc., 2855 Gazelle Court
Carlsbad, CA 92010, US | Applicant ref. no. | P65670DK01 | Inventor | RIGO, Frank, 2855 Gazelle Court
Carlsbad, CA 92010, US, WARD, Amanda, 2855 Gazelle Court
Carlsbad, CA 92010, US, BEAUDET, Arthur, L., 3731 Barbara Lane
Houston, TX 77005, US, MENG, Linyan, 7575 Cambridge Street
Houston, TX 77054, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/7088 (2006.01) , C12N 15/113 (2010.01) | Title | MODULATION AF UBE3A-ATS-EKSPRESSION | Int. application no. | US2013047701 | Int. publication no. | WO2014004572 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|